<DOC>
	<DOCNO>NCT01046981</DOCNO>
	<brief_summary>Tumescent Antibiotic Delivery ( TAD ) technique improve prevention surgical site infection ( SSI ) . TAD involve subcutaneous infiltration tumescent local anesthesia ( TLA ) contain water soluble antibiotic ( ) cefazolin metronidazole . TLA consist subcutaneous infiltration dilute lidocaine ( ≤ 1 gram/liter ) epinephrine ( ≤ 1 milligram/liter ) sodium bicarbonate ( 10 milliequivalents/liter ) physiologic solution sodium chloride produce intense local anesthesia associate profound wide-spread vasoconstriction last 12 hour . Compared intravenous antibiotic delivery ( IVAD ) , TAD expect produce high local tissue concentration antibiotic ( ) long period time low systemic/serum antibiotic concentration . This clinical trial compare TAD IVAD respect pharmacokinetic evidence possible improve SSI prevention .</brief_summary>
	<brief_title>Tumescent Antibiotic Delivery Pharmacokinetics</brief_title>
	<detailed_description>The protocol entitle Absorption Kinetics Subcutaneous Tumescent Cefazolin Metronidazole Phase I dose range clinical study design document concentration-time profile cefazolin lidocaine subcutaneous infiltration cefazolin tumescent local anesthesia ( TLA ) . The antibiotic cefazolin routinely give intravenously ( IV ) prophylaxis surgical site infection ( SSI ) . Tumescent local anesthesia ( TLA ) consist subcutaneous infiltration dilute lidocaine ( ≤ 1 gram/liter ) epinephrine ( ≤ 1 milligram/liter ) sodium bicarbonate ( 10 milliequivalents/liter ) physiologic solution sodium chloride . Clinically TLA produce intense local anesthesia associate profound wide-spread vasoconstriction last 12 hour . Tumescent delivery cefazolin refers subcutaneous infiltration cefazolin dissolve dilute solution tumescent local anesthesia . For number surgical procedure current standard care prophylaxis surgical site infection ( SSI ) IV antibiotic ( e.g . cefazolin ) administer within 30 60 minute surgical incision . We hypothesize tumescent delivery cefazolin may effective prevent SSI possibly safer few side effect compare IV delivery cefazolin . This protocol preliminary step explore possibility tumescent delivery cefazolin well standard IV delivery prevention SSI . The present protocol phase I study document compare serum tissue cefazolin level IV subcutaneous tumescent delivery . A finding tumescent delivery provide prolonged tissue level cefazolin justify phase II study tumescent cefazolin site anticipated surgical incision SSI prevention . • Summary Experimental Design Clinical Trial Protocol The tumescent cefazolin study protocol organize follow . The tumescent cefazolin clinical study protocol involve four adult volunteer subjects/participants . Each subject participate four ( 4 ) separate 12 24-hour investigative procedure least one two week apart . Concentrations drug solution tumescent local anesthesia : lidocaine ≤ 1000 mg/L , epinephrine ≤ 1.0 mg/L , sodium bicarbonate 10 meq/L , cefazolin ≤ 1 gm/L without metronidazole 500mg/L . Maximum total cefazolin dose 1 gm . The maximum total metronidazole dose 500 mg . The maximum tumescent lidocaine dosage 20 mg/kg . TLA deliver subcutaneous fat peristaltic infiltration pump use blunt-tipped infiltration cannula . Procedures 1 &amp; 2 : Subcutaneous infiltration tumescent cefazolin : Two four investigative procedure begin infiltration solution tumescent local anesthesia contain cefazolin . Following infiltration subcutaneous tumescent local anesthesia contain cefazolin approximately 9 sequential blood tissue sample take 12 24 hour . In two study minimal volume liposuction ( 10 ml 12 ml use hand hold syringe ) do order obtain sample subcutaneous fat tumescent subcutaneous interstitial tissue-fluid measurement cefazolin metronidazole concentration . Procedure 3 : IV infusion cefazolin metronidazole : In control study patient give 1 gm IV cefazolin without 500 mg metronidazole subsequent sequential serum sample antibiotic concentration obtain 12 hour . Serum Samples : Sequential sample serum fat obtain 0 , 1 , 3 , 6 , 9 , 12 , 18 , 24 hour ( T0 , T1 , T3 , T6 , T9 , T12 , T15 , T18 T24 ) , T0 = time completion tumescent infiltration IV infusion . Serum sample obtain peripheral vein via indwell catheter analyze cefazolin concentration HPLC . Tissue Fluid Samples : Samples subcutaneous tissue fluid obtain liposuction approximately 10 ml subcutaneous fat tumescent anesthetic solution use hand-held syringe , aspirate centrifuge obtain aqueous infranate cefazolin , metronidazole lidocaine concentration measure HPLC . Clinical experience show tumescent local anesthesia persist least 12 hour . If patient experience significant discomfort aspiration subcutaneous fat use hand-held syringe , subcutaneous tissue sample take duration clinical procedure .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Cefazolin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Healthy adult No allergy cefazolin , metronidazole lidocaine HIV Hepatitis C Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Surgical site infection</keyword>
	<keyword>Prevention</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Tumescent</keyword>
	<keyword>Intravenous</keyword>
	<keyword>Antibiotic</keyword>
	<keyword>Absorption</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Bioavailability</keyword>
</DOC>